Table 1 |
||||||||
|
Odds ratio (OR) and corresponding 95% confidence intervals (CI) for lack of Pap-smear in the last year by selected characteristics |
||||||||
|
Pap-smear in the last year |
||||||||
|
|
||||||||
|
Yes |
No |
OR† |
(95%CI) |
OR‡ |
(95%CI) |
|||
|
|
||||||||
|
n |
(%) |
n |
(%) |
|||||
|
|
||||||||
|
Total |
607 |
(60.6) |
395 |
(39.4) |
||||
|
Age at interview (years) |
||||||||
|
≥45 |
145 |
(58.7) |
102 |
(41.3) |
1 |
1 |
||
|
40-44 |
227 |
(65.6) |
119 |
(34.4) |
0.8 |
(0.5-1.1) |
0.8 |
(0.5-1.1) |
|
35-39 |
131 |
(63.3) |
76 |
(36.7) |
0.8 |
(0.6-1.2) |
0.8 |
(0.6-1.2) |
|
<35 |
104 |
(51.5) |
98 |
(48.5) |
1.4 |
(1.0-2.0) |
1.2 |
(0.8-1.8) |
|
Education level |
||||||||
|
High school/University |
255 |
(63.1) |
149 |
(36.9) |
1 |
1 |
||
|
Middle school/Primary |
241 |
(55.9) |
190 |
(44.1) |
1.3 |
(1.0-1.7) |
1.3 |
(1.0-1.7) |
|
Area of birth |
||||||||
|
Italy |
495 |
(62.1) |
302 |
(37.9) |
1 |
1 |
||
|
Abroad |
112 |
(54.6) |
93 |
(45.4) |
1.2 |
(0.8-1.7) |
1.1 |
(0.8-1.6) |
|
Central-Eastern Europe§ |
17 |
(42.5) |
23 |
(57.5) |
1.8 |
(0.9-3.6) |
1.7 |
(0.8-3.3) |
|
Africa |
56 |
(53.3) |
49 |
(46.7) |
1.3 |
(0.8-2.0) |
1.1 |
(0.7-1.9) |
|
Other countries |
39 |
(65.0) |
21 |
(35.0) |
0.8 |
(0.5-1.5) |
0.9 |
(0.5-1.5) |
|
Mode of HIV acquisition |
||||||||
|
Sexual |
336 |
(62.1) |
205 |
(37.9) |
1 |
1 |
||
|
Injecting drug use |
164 |
(61.0) |
105 |
(39.0) |
1.2 |
(0.9-1.6) |
1.1 |
(0.8-1.6) |
|
Other/Unknown |
107 |
(55.7) |
85 |
(44.3) |
1.2 |
(0.8-1.6) |
1.1 |
(0.7-1.5) |
|
Time since first HIV+ test (years) |
||||||||
|
≥10 |
357 |
(63.2) |
208 |
(36.8) |
1 |
1 |
||
|
3-9 |
169 |
(62.1) |
103 |
(37.9) |
0.9 |
(0.7-1.3) |
0.9 |
(0.7-1.3) |
|
≤2 |
78 |
(48.4) |
83 |
(51.6) |
1.4 |
(1.0-2.1) |
1.3 |
(0.9-2.0) |
|
Previous AIDS diagnosis |
||||||||
|
No |
504 |
(61.3) |
318 |
(38.7) |
1 |
1 |
||
|
Yes |
103 |
(57.2) |
77 |
(42.8) |
1.2 |
(0.9-1.7) |
1.2 |
(0.9-1.7) |
|
CD4 count at last visit (cells/μl) |
||||||||
|
≥500 |
284 |
(63.5) |
163 |
(36.5) |
1 |
1 |
||
|
200-499 |
271 |
(58.8) |
190 |
(41.2) |
1.2 |
(0.9-1.6) |
1.2 |
(0.9-1.5) |
|
<200 |
45 |
(51.7) |
42 |
(48.3) |
1.6 |
(1.0-2.5) |
1.6 |
(1.0-2.6) |
|
Screening advice received from |
||||||||
|
Infectivologist |
244 |
(66.8) |
121 |
(33.2) |
1 |
1 |
||
|
Gynecologist |
122 |
(77.2) |
36 |
(22.8) |
0.6 |
(0.4-0.9) |
0.6 |
(0.4-1.0) |
|
Screening program |
61 |
(59.8) |
41 |
(40.2) |
1.4 |
(0.9-2.2) |
1.3 |
(0.8-2.1) |
|
Do not remember |
180 |
(47.7) |
197 |
(52.3) |
2.1 |
(1.5-2.8) |
2.2 |
(1.6-2.9) |
|
Hospitalized for HIV |
||||||||
|
No |
382 |
(61.8) |
236 |
(38.2) |
1 |
1 |
||
|
Yes |
225 |
(58.6) |
159 |
(41.4) |
1.2 |
(0.9-1.5) |
1.2 |
(0.9-1.5) |
|
Abnormal Pap-smear# |
||||||||
|
Never |
366 |
(61.7) |
227 |
(38.3) |
1 |
1 |
||
|
Ever |
235 |
(77.0) |
70 |
(23.0) |
0.5 |
(0.3-0.6) |
0.4 |
(0.3-0.6) |
|
|
||||||||
|
Emilia-Romagna region, Italy, 2006-2007* * Figures may not add up to totals because of missing values. †Estimates from the logistic regression models adjusted for age and study centre; ‡Adjusted as † plus terms for area of birth, mode of HIV acquisition, and time since first HIV-positive test. §Included Albania, Bulgaria, Former-Yugoslavia, Poland, Romania, Hungary, Former-USSR, Czech Republic and Slovakia, Cyprus; #Women reporting no previous Pap-smear were excluded |
||||||||
|
Dal Maso et al. BMC Cancer 2010 10:310 doi:10.1186/1471-2407-10-310 |
||||||||
